DNMR - Danimer Scientific GAAP EPS of -$0.36 beats by $0.02 revenue of $11.9M misses by $2.49M
2023-05-10 16:04:47 ET
- Danimer Scientific press release ( NYSE: DNMR ): Q1 GAAP EPS of -$0.36 beats by $0.02 .
- Revenue of $11.9M (-19.3% Y/Y) misses by $2.49M .
- Gross profit was $(6.3) million compared to $(1.3) million in the first quarter of 2022. Adjusted gross profit was $(1.0) million compared to $2.0 million in the first quarter of 2022.
- Net loss for the first quarter was $(36.6) million compared with $(26.4) million in the prior year period.
- Adjusted EBITDA in the first quarter of 2023 improved to $(8.9) million as compared to $(10.6) million in the first quarter of 2022 due to successful expense controls across many areas of the business.
- Full-year Adjusted EBITDA in the range of $(23) million to $(31) million.
- Full-year capital expenditures are anticipated to be in the range of $26 million to $31 million, primarily to support existing commitments related to the Bainbridge greenfield facility.
For further details see:
Danimer Scientific GAAP EPS of -$0.36 beats by $0.02, revenue of $11.9M misses by $2.49M